Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJun 06, 2017 5:00 pm

Barfresh Food Group Inc. (BRFH) Starts Presentation at LD Micro 2017 Invitational

Barfresh Food Group (OTC: BRFH) is a developer, manufacturer and distributor of ready-to-blend beverages, including smoothies, shakes and frappes, primarily for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages without waste that are quick and cost efficient. PepsiCo North America Beverages, a division of PepsiCo, Inc., is the exclusive sales representative in North America within the food service channel for Barfresh's full line of beverages. For more information, visit the company's website at www.barfresh.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users…

Continue Reading

TuesdayJun 06, 2017 4:30 pm

MariMed, Inc. (MRMD) Starts Presentation at LD Micro 2017 Invitational

MariMed (OTCQB: MRMD), formerly Worlds Online, is an industry leader in the design, development, operation, funding and optimization of medical cannabis cultivation and production centers and dispensaries. The company has developed state-of-the-art, regulatory-compliant facilities in multiple states that leverage a scalable model of excellence leaning on well-defined horticultural principles related to cannabis production, product development and dispensary operations. MariMed’s turnkey solutions, including a wide array of management and advisory services, help cannabis cultivators, producers and dispensaries better address the needs of their patients by enabling the reliable production and delivery of high quality, tested cannabis flower and cannabis products. For…

Continue Reading

TuesdayJun 06, 2017 4:30 pm

Kindred Biosciences, Inc. (NASDAQ: KIN) Starts Presentation at LD Micro 2017 Invitational

Kindred Biosciences (NASDAQ: KIN) is a development-stage biopharmaceutical company that focuses on the development of therapies for pets. The company’s product pipeline consists of small molecules and biologics for a range of indications in dogs, cats and horses. Its lead product candidates include Zimeta, a dipyrone injection for the control of pyrexia (fever) in horses; and Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats. The company's other small molecule product candidates consist of KIND-014 for the treatment of equine gastric ulcers in horses; and KIND-015 for the management of clinical signs associated with equine metabolic…

Continue Reading

TuesdayJun 06, 2017 4:00 pm

Atossa Genetics, Inc. (NASDAQ: ATOS) Starts Presentation at LD Micro 2017 Invitational

Atossa Genetics (NASDAQ: ATOS) is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods to treat breast cancer and other breast conditions. The company’s leading program utilizes patented intraductal microcatheters, which deliver pharmaceuticals through the breast milk ducts. In March 2016, Atossa initiated a Phase 2 clinical study of these microcatheters to deliver fulvestrant as a potential treatment for ductal carcinoma in-situ, or DCIS, and breast cancer. For more information, visit the company’s website at www.atossagenetics.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and…

Continue Reading

TuesdayJun 06, 2017 4:00 pm

A-Mark Precious Metals, Inc. (NASDAQ: AMRK) Starts Presentation at LD Micro 2017 Invitational

A-Mark Precious Metals (NASDAQ: AMRK) operates as a precious metals trading company worldwide. The company offers gold, silver, platinum and palladium in the form of bars, plates, powder, wafers, grains, ingots and coins, as well as distributes gold and silver coins and bars from sovereign and private mints. It also provides loans on precious metals, rare coins, and other collectibles collateral to coin dealers, collectors and investors; storage solutions for precious metals and numismatic coins for financial institutions, dealers, investors and collectors; and a range of logistics services. For more information, visit the company's website at www.amark.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

TuesdayJun 06, 2017 4:00 pm

CV Sciences, Inc. (CVSI) Starts Presentation at LD Micro 2017 Invitational

CV Sciences (OTC: CVSI) is a life science company that focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments: Specialty Pharmaceutical and Consumer Product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods, and vape. The company was formerly known as CannaVEST Corp. and changed its name to CV Sciences in January 2016. CV Sciences was founded in 2010 and is based in Las Vegas, Nevada. For more information, visit the company's website at www.cvsciences.com. About NetworkNewsWire…

Continue Reading

TuesdayJun 06, 2017 3:30 pm

Exactus, Inc. (EXDI) Starts Presentation at LD Micro 2017 Invitational

Exactus (OTC: EXDI) is a life science company that engages in developing point-of-care (POC) diagnostics for measuring proteolytic enzymes in the blood. It develops products to make patient data available to healthcare providers in a way that is unmatched. Exactus addresses healthcare gaps with easy-to-use, portable devices that reduce the time required to return analysis on patient blood and collagenase activity. Its POC diagnostic tools use patented technology to analyze biometric markers in a single drop of blood, revealing insights into patient health. The company is based in Glen Allen, Virginia. For more information, visit the company's website at www.exactusinc.com…

Continue Reading

TuesdayJun 06, 2017 3:30 pm

Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) Starts Presentation at LD Micro 2017 Invitational

Perma-Fix Environmental (NASDAQ: PESI) is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy ("DOE"), the Department of Defense ("DOD"), and the commercial nuclear industry. Perma-Fix Environmental’s nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD,…

Continue Reading

TuesdayJun 06, 2017 3:30 pm

Legacy Education Alliance, Inc. (LEAI) Starts Presentation at LD Micro 2017 Invitational

Legacy Education Alliance (OTCQB: LEAI) is an international leader in providing practical, high-quality and value-based education training on the subjects of personal finance, entrepreneurship, real estate and financial markets investing strategies and techniques. Founded in 1996, the company has become a global enterprise supported by about 200 employees and has cumulatively served over 2 million students from more than 150 countries and territories. Legacy Education Alliance offers training through various brands, including Rich Dad® Education, Rich Dad® Stock Education, Making Money from Property with Martin RobertsTM, Brick Buy BrickTM, Building Wealth, Robbie Fowler Property AcademyTM, Women in WealthTM, The Independent…

Continue Reading

TuesdayJun 06, 2017 3:00 pm

CytoDyn, Inc. (CYDY) Starts Presentation at LD Micro 2017 Invitational

CytoDyn (OTC: CYDY) is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished phase 2 clinical trials with demonstrated antiviral activity in man. PRO 140 blocks the HIV co-receptor CCR5 on T-cells that prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from six phase 1 and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000